Sagent Pharmaceuticals, Inc. (SGNT) Misses Q1 EPS by 2c

May 10, 2012 5:01 PM EDT
Get Alerts SGNT Hot Sheet
Trade SGNT Now!
Join SI Premium – FREE
Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) reported Q1 EPS of ($0.30), $0.02 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $38.3 million versus the consensus estimate of $42.31 million.

For earnings history and earnings-related data on Sagent Pharmaceuticals, Inc. (SGNT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment